News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Harbour Antibodies Licenses H2L2 Mice to Pfizer Inc. (PFE)



7/24/2013 9:46:27 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ROTTERDAM, the Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Harbour Antibodies, the creator of transgenic mice to aid in the development of new human therapeutic antibodies, announced today that it has licensed its H2L2 mice, which can generate human monoclonal antibodies, to Pfizer Inc.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES